BioSig Technologies Inc (NASDAQ:BSGM) CEO Kenneth Londoner tells Proactive it has installed its PURE EP ECG signal processing platform system at New York-Presbyterian/Weill Cornell Medical Center in New York.
Londoner says the northeast is one of the three strategic areas that the BioSig is focused on in its targeted commercial launch phase.